Sequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney Transplantation
Institute for Clinical and Experimental Medicine
Institute for Clinical and Experimental Medicine
Northwestern University
University of Pittsburgh
National Institutes of Health Clinical Center (CC)
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Weill Medical College of Cornell University
Weill Medical College of Cornell University
Northwestern University
M.D. Anderson Cancer Center
University of California, San Diego
Mayo Clinic
Baylor College of Medicine
St. Jude Children's Research Hospital
Mayo Clinic
University of California, San Francisco
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Arizona
M.D. Anderson Cancer Center
Columbia University
National Institutes of Health Clinical Center (CC)
University of California, San Francisco
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
University of Arizona
University of Chicago
Baylor College of Medicine
Sanofi
Baylor College of Medicine
Baylor College of Medicine
Baylor College of Medicine
Northwell Health
National Cancer Institute (NCI)
Stanford University
Mayo Clinic
National Cancer Institute (NCI)
Sanofi
Sanofi
University of Chicago
Northside Hospital, Inc.
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center